Hengshan Pharmaceutical

The Shanghai Municipal Medical Products Administration has disclosed that Hengshan (H&S) Pharmaceutical is under scrutiny for the alleged manufacture of substandard medications. The company faces not only the seizure of the non-compliant drugs but also a financial penalty. H&S Pharmaceutical has been charged RMB 295,753.58 for the illicit proceeds derived…